Skip to main content

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 2,101–2,120 of 18,047 drug recalls

Drug Recall Ongoing Historical recordClass II

NYSTATIN 500 MU, Activity (as is): 6482 Units/mg, bulk powder container, Rx Only, For Prescription Compounding, Fagron, Inc. - 2400 Pilot Knob Rd. St Paul, MN 55120. NDC 51552-0041-3, Bar code 3 51552 00413 9

by Fagron, Inc

Reason
Labeling: Label Error on Declared Strength: Assay value on the label is incorrect.
Recall initiated
December 11, 2023
Reported by FDA
December 27, 2023
Distribution
Product was distributed to 1 distributor and may have further distributed the product to repacker/relabelers and pharmacies in the United States and Canada to be used for prescription compounding.

View recall →

Drug Recall Ongoing Historical recordClass II

NYSTATIN 5BU, Activity (as is): 6482 Units/mg, bulk powder container, Rx Only, For Prescription Compounding, Fagron, Inc. - 2400 Pilot Knob Rd. St Paul, MN 55120. NDC 51552-0041-5 Bar code 3 51552 00415 3

by Fagron, Inc

Reason
Labeling: Label Error on Declared Strength: Assay value on the label is incorrect.
Recall initiated
December 11, 2023
Reported by FDA
December 27, 2023
Distribution
Product was distributed to 1 distributor and may have further distributed the product to repacker/relabelers and pharmacies in the United States and Canada to be used for prescription compounding.

View recall →

Drug Recall Terminated Historical recordClass I

Phenytoin Oral Suspension, USP, 100 mg/4 mL, packaged in packaged in 4 mL unit dose cups (NDC 0904-7079-24), 50 per case (NDC 0904-7079-57), Rx only, Major Pharmaceuticals Livonia, MI 48152

by The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories

Reason
Failed Content Uniformity Specifications
Recall initiated
October 23, 2023
Reported by FDA
December 27, 2023
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing Historical recordClass II

Selenium Sulfide 2.25% Shampoo, 180mL bottle, Rx Only, Manufactured for: Bi-Coastal Pharma Int. LLC, Shrewsbury, NJ 07702, NDC 42582-900-06.

by Private Label Partners, Inc.

Reason
CGMP Deviations: Stability data does not support expiry date.
Recall initiated
December 13, 2023
Reported by FDA
December 27, 2023
Distribution
NJ

View recall →

Drug Recall Completed Historical recordClass I

TING 2% Miconazole Nitrate Athlete's Foot Spray Antifungal Spray Powder, NET WT 4.5 oz (128 g) cans, Distributed by: Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company, Tarrytown, NY 10591, UPC 363736532611.

by Insight Pharmaceuticals Corporation

Reason
Chemical Contamination; presence of benzene.
Recall initiated
November 22, 2023
Reported by FDA
December 27, 2023
Distribution
Nationwide and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass II

Liothyronine Sodium Tablets, USP 5 mcg, 100-count bottle, Rx Only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 Manufactured by: Sun Pharmaceutical Industries Ltd. Survey No. 259/15, Dadra-396 191, (U.T. of D & NH), India. NDC 62756-589-88

by SUN PHARMACEUTICAL INDUSTRIES INC

Reason
Failed Impurities/Degradation Specifications
Recall initiated
December 4, 2023
Reported by FDA
December 20, 2023
Distribution
Nationwide

View recall →

Drug Recall Completed Historical recordClass III

Votrient (pazopanib) 200 mg tablets, 120-count bottle, Rx Only, Manufactured by: Siegried Barbera, S.L., Barbera del Valles, Spain, Distributed by: Novartis Pharmaceuticals Corp., East Hanover, N.J. 07936, NDC 0078-1077-66

by Siegfried Barbera, SL

Reason
Failed Dissolution Specifications
Recall initiated
November 20, 2023
Reported by FDA
December 20, 2023
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Penicillamine Tablets USP 250 mg, 100-count bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202 Manufactured by: Lupin Limited, Nagpur-441 108, India, NDC# 70748-153-01

by Lupin Pharmaceuticals Inc.

Reason
Failed Dissolution Specifications
Recall initiated
November 22, 2023
Reported by FDA
December 20, 2023
Distribution
Product was distributed to 3 wholesale/distributor accounts.

View recall →

Drug Recall Completed Historical recordClass II

ROPivacaine HCl 0.2% PF in Sodium Chloride 1,000 mg/500 mL (2 mg per mL) Injection, 500 mL bags, Rx only, STAQ Pharma Inc. 14135 E 42nd Ave, Unit 50, Denver, Colorado 80239, NDC 73177-0109-26,

by STAQ Pharma, Inc.

Reason
STAQ Pharma Inc. received consumer complaints related to leaking bags and other potential bag concerns. Upon investigation, they determine the source of the issue was with the bag manufacturer who released bags Lot # 134142-001A which had failed internal QC tests for leaks.
Recall initiated
November 29, 2023
Reported by FDA
December 13, 2023
Distribution
Nationwide within the United States

View recall →

Drug Recall Completed Historical recordClass II

Ondansetron Injection, USP, 4 mg/2 mL (2 mg/mL), 2 mL per vial, Rx only, Manufactured for: Baxter Healthcare Corporation, Deerfield, IL 60015 USA. Manufactured by: Baxter Pharmaceuticals India Private Ltd, Ahmedabad 382213, India. NDC 36000-012-25

by Baxter Healthcare Corporation

Reason
Failed pH Specifications
Recall initiated
November 14, 2023
Reported by FDA
December 13, 2023
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing Historical recordClass I

SANDIMMUNE Oral Solution (cyclosporine oral solution, USP) 100 mg/mL, 50 mL bottle, Rx Only, Manufactured by: DELPHARM Huningue S.A.S., Huningue, France, Distributed by: Novartis Pharmaceuticals Corporation, East Hanover, New Jersey 07936. NDC 0078-0110-22

by Novartis Pharmaceuticals Corporation

Reason
Crystallization: bottles of Sandimmune Oral Solution were determined to contain crystals
Recall initiated
November 22, 2023
Reported by FDA
December 13, 2023
Distribution
Nationwide within the United States

View recall →

Drug Recall Ongoing Historical recordClass II

KinderMed INFANTS' PAIN & FEVER Acetaminophen, 160 mg per 5 mL bottles, Oral Suspension, Organic Cherry Flavor, 2 FL OZ (59 mL), Distributed By: KinderFarms, Redondo Beach, CA 90277, NDC 82673-096-02, UPC 850001805698.

by KINDER FARMS LLC

Reason
Failed Impurities/Degradation Specifications
Recall initiated
November 13, 2023
Reported by FDA
December 13, 2023
Distribution
Nationwide

View recall →

Drug Recall Ongoing Historical recordClass II

KinderMed KIDS' PAIN & FEVER Acetaminophen, 160 mg per 5 mL bottles, Oral Suspension, Organic Cherry Flavor, 4 FL OZ (118 mL), Distributed By: KinderFarms, Redondo Beach, CA 90277, NDC 82673-097-04, UPC 850001805728.

by KINDER FARMS LLC

Reason
Failed Impurities/Degradation Specifications
Recall initiated
November 13, 2023
Reported by FDA
December 13, 2023
Distribution
Nationwide

View recall →

Drug Recall Completed Historical recordClass II

ceFAZolin sodium in Sterile Water for injection, Injectable Solution, 1g/10mL (0.1 g per mL), Syringe, Rx only, Wells Pharma, NDC 73702-131-10

by Wells Pharma of Houston LLC

Reason
Lack of assurance of sterility.
Recall initiated
November 22, 2023
Reported by FDA
December 13, 2023
Distribution
Philadelphia, Pennsylvania.

View recall →

Drug Recall Terminated Historical recordClass III

LET Gel (Lidocaine HCL/Epinephrine Bitartrate/Tetracaine HCL 4%/0.18%/0.5% Topical Gel), Single-use Topical Syringe, 3mL syringe, 10/pack, Rx only, Carie Boyd Pharmaceuticals, 8400 Esters Blvd, Ste# 190, Irving, TX 75063, NDC73271-1003-1

by Right Value Drug Stores, LLC dba Carie Boyd's Prescription Shop

Reason
Product Mix-up: Incorrect Product Formulation
Recall initiated
November 9, 2023
Reported by FDA
December 13, 2023
Distribution
USA Nationwide

View recall →

Drug Recall Ongoing Historical recordClass II

Trospium Chloride Extended-Release Capsules, 60 mg, 30 Capsules per bottle, Rx Only, Manufactured By: Sidmak Laboratories (India) Pvt. Ltd. Plot No. 20, Pharmacity, Selaqui Industrial Area, Dehradun-248 197 Uttarakhand, India Distributed By: Padagis, Allegan, MI 49010. NDC: 0574-0118-30

by Padagis US LLC

Reason
Failed Tablets/Capsules specifications; missing/broken/extra tablets within the capsules
Recall initiated
November 1, 2023
Reported by FDA
December 13, 2023
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing Historical recordClass I

Dr. Ergin's SugarMD, ADVANCED GLUCOSE SUPPORT Capsules, Dietary Supplement, helps support healthy glucose levels a) 60 count (UPC 1 95893 92767 8), b) 120 count (UPC 1 95893 54697 8), c) 180 count (UPC 1 95893 99957 6) bottles, Manufactured for SUGARMDS LLC, Port St. Lucie, FL 34952.

by SUGARMDS LLC

Reason
MARKETED WITHOUT AN APPROVED NDA/ANDA: Product found to be tainted with metformin and glyburide
Recall initiated
November 8, 2023
Reported by FDA
December 13, 2023
Distribution
U.S. Nationwide and online websites.

View recall →

Drug Recall Terminated Historical recordClass III

buPROPion Hydrochloride Extended-Release Tablets, USP (SR) 200 mg, 60 Tablets bottle, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited, Halol-Baroda Highway, Halol-389 350, Gujarat, India NDC 47335-738-86

by SUN PHARMACEUTICAL INDUSTRIES INC

Reason
Failed Dissolution Specifications
Recall initiated
November 22, 2023
Reported by FDA
December 13, 2023
Distribution
Nationwide

View recall →

Drug Recall Ongoing Historical recordClass I

Kuka Flex Forte caplets, packaged in 30-count bottles, Manufactured by: Kukamonga, Gonzalez Ortega No 170 Col Centro, 44100 Guadalajara Jal, UPC 0736640810265

by Botanical Be

Reason
Marketed Without an Approved NDA/ANDA: products found to contain undeclared diclofenac.
Recall initiated
October 20, 2023
Reported by FDA
December 6, 2023
Distribution
USA Nationwide

View recall →

Drug Recall Ongoing Historical recordClass I

Reumo Flex caplets, packaged in 30-count boxes, Manufactured by: Grupo Yepenza de Mexico, SA de CV, Comerciantes 5824 Col Arcos de Guadalupe, Zapopan Jal Mexico, UPC 7 502214 014598

by Botanical Be

Reason
Marketed Without an Approved NDA/ANDA: products found to contain undeclared diclofenac.
Recall initiated
October 20, 2023
Reported by FDA
December 6, 2023
Distribution
USA Nationwide

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.

Reconnecting to the server…

We lost the connection to the server.

Your session has expired.